Pilot in vitro toxicity study of 5-ALA and Photofrin in microvascular endothelial cell cultures
- PMID: 9612183
- DOI: 10.1089/clm.1997.15.83
Pilot in vitro toxicity study of 5-ALA and Photofrin in microvascular endothelial cell cultures
Abstract
Complicated hemangiomas are unique problems in which intervention with the proper laser can be an ideal solution. In this study we evaluated the toxicity of 5-Aminolevulinic acid (5-ALA) and Photofrin using in vitro models. The in vitro toxicity of 5-ALA and Photofrin was examined in a microvascular endothelial cell (MEC) culture system. The measurement of the percentage of MEC killed by various drug concentration using fluorescence viability assay. MEC incubated with 5-ALA at various concentrations for evaluation of dark toxicity showed less than a 50% cell kill. A comparison of different intervals of subcultured MEC showed that the early subculture (3 days after primary culture) is more vulnerable than later subculture (7 days after). Cells treated with Photofrin at various concentrations exhibited less than 50% cell kill (dark toxicity). The comparison of different intervals of subculture (3 days and 7 days after primary culture) showed a result similar to that of 5-ALA. All controls showed 0% cell kill. In conclusion, both 5-ALA and Photofrin are capable of destroying human microvascular endothelial cells in vitro. Drug concentrations and the power density for photodynamic therapy should be considered and will be included in our subsequent studies.
Similar articles
-
In vitro and in vivo photosensitizing capabilities of 5-ALA versus photofrin in vascular endothelial cells.Lasers Surg Med. 1999;24(3):178-86. doi: 10.1002/(sici)1096-9101(1999)24:3<178::aid-lsm2>3.0.co;2-w. Lasers Surg Med. 1999. PMID: 10229148
-
In vitro and in vivo photosensitizing capabilities of 5-ALA in vascular endothelial cells.Changgeng Yi Xue Za Zhi. 1999 Jun;22(2):181-8. Changgeng Yi Xue Za Zhi. 1999. PMID: 10493021
-
Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.Cancer Res. 2001 Aug 1;61(15):5824-32. Cancer Res. 2001. PMID: 11479222
-
Relation of early Photofrin uptake to photodynamically induced phototoxicity and changes of cell volume in different cell lines.Eur J Cancer. 1994;30A(1):78-83. doi: 10.1016/s0959-8049(05)80023-1. Eur J Cancer. 1994. PMID: 8142170
-
Comparative in vitro study on the characteristics of different photosensitizers employed in PDT.J Photochem Photobiol B. 2010 Sep 2;100(3):173-80. doi: 10.1016/j.jphotobiol.2010.06.004. Epub 2010 Jun 17. J Photochem Photobiol B. 2010. PMID: 20599390
Cited by
-
Photodynamic therapy: a review.Drugs Aging. 1999 Jul;15(1):49-68. doi: 10.2165/00002512-199915010-00005. Drugs Aging. 1999. PMID: 10459732 Review.
-
The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells.Lasers Med Sci. 2013 Feb;28(2):605-14. doi: 10.1007/s10103-012-1119-y. Epub 2012 May 15. Lasers Med Sci. 2013. PMID: 22585382
-
High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.Kidney Int. 2015 Aug;88(2):386-95. doi: 10.1038/ki.2015.97. Epub 2015 Apr 1. Kidney Int. 2015. PMID: 25830761
-
Imaging and Histopathological Analysis of Microvascular Angiogenesis in Photodynamic Therapy for Oral Cancer.Cancers (Basel). 2023 Feb 9;15(4):1110. doi: 10.3390/cancers15041110. Cancers (Basel). 2023. PMID: 36831454 Free PMC article.
-
Porphyria and kidney diseases.Clin Kidney J. 2018 Apr;11(2):191-197. doi: 10.1093/ckj/sfx146. Epub 2018 Jan 10. Clin Kidney J. 2018. PMID: 29644058 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical